Incidence and diagnosis, cellular mechanisms and pathogenesis of Creutzfeldt-Jakob disease and other prion diseases.
The clinical neurologists, neuropathologists and scientists at the National CJD Research and Surveillance Unit, in collaboration with the Roslin Institute, monitor the characteristics of CJD, identify trends in incidence, study risk factors and contribute to improving the quality of care for those with CJD.
|Diagnostic services and the development of new diagnostic tests & biomarkers||Alison Green|
|Molecular and cellular aspects of protein misfolding||Mark Head|
|Mechanisms of neurodegeneration and neuroprotection||Jean Manson|
|CJD epidemiology, clinico-pathological characterisation, diagnostics & public health||Richard Knight|
|Neuropathological phenotype, distribution of abnormal prion protein & neurodegenerative pathology||James Ironside|
|Epidemiology, surveillance & public health||Anna Molesworth|
|Diagnosis, epidemiology & public health||Robert Will|